Dale Binke New VP at Expanding Orthopedics

Dale Binke is the new Vice President of U.S. Sales at Expanding Orthopedics Inc. (EOI).

According to the April 12, 2016 news release, “Dale joins EOI with more than 26 years of experience in the medical device industry, including senior leadership roles with Medtronic, AlloSource, Spinal Elements and most recently with Trinity Orthopedics. In his previous positions, Dale was very successful driving market expansion and revenue growth as well as establishing strategic relationships with surgeons and industry players.”

Binke stated, “I am thrilled to join EOI, one of the fastest growing young spine companies, and use my extensive sales experience and broad spine network to drive the sales of the FLXfit expandable cage to the next level. I’m excited with the company’s pipeline of innovative spine products and its ability to fast execute to become a leader in the expanding devices’ market.”

Ofer Bokobza, EOI’s CEO, commented: “Dale’s extensive experience in the spine industry will bring immense value to EOI’s team and will reinforce its sales and distribution resources in the U.S. We see a steady increase of U.S. surgeons adopting the FLXfit as their preferred choice of treatment. Dale’s appointment is our first step of growing our U.S. infrastructure to support the FLXfit successful adoption in the market as well as the pipeline of innovative products underway.”

Binke told OTW, “Expanding Orthopedics’ platform technology focus on aiding surgeons to dial in a customized lordosis. The FLXfit Expandable Cage is the only device designed with centralized articulation within the actual cage and the ability to continuously expand to 10 degrees of lordosis. This proprietary feature allows surgeons utilizing TLIF approaches to consistently place our FLXfit cage centrally along the anterior disk space’s epiphyseal ring. Once in position, simple expansion and individual patient lordosis is achieved in a balanced fashion covering the majority of the anterior space. Our device has the largest footprint available and is a major advancement in aiding surgeons’ desire of sagittal alignment.”

“EOI has done an exceptional job with early commercialization efforts. As we move forward we need to further demonstrate the clinical benefits of our technologies through rigorous clinical data. The healthcare environment will continue to challenge all of us to demonstrate outcomes to validate medical treatments and procedures. We will proactively seek out like minded surgeons who commonly share in our mission.”